CVS Q2 Beats Wall Street Expectations

CVS Q2 Beats Wall Street Expectations

In the second quarter, CVS Health topped analyst estimates although front end comparable sales slipped slightly after a 10% gain in the 2022 period. Company net income was $1.9 billion, or $1.48 per diluted share, versus $3.03 billion, or $2.29 per diluted share, in...